Search

everythinglearnresearchcommunity

for

Search:↓

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Shift work disrupts the body's natural clock, leading to health problems.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Tph cells are linked to the severity of systemic lupus erythematosus.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Hydroxychloroquine may help delay skin damage in lupus patients.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

A risk prediction model can help diagnose systemic lupus erythematosus earlier in primary care.

COVID-19 vaccination may trigger lupus in some people.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Hair loss in lupus patients indicates higher disease activity.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Cutaneous lupus erythematosus is a chronic skin disease that can progress to systemic lupus in some cases and requires treatment to prevent recurrences and scarring.

Lichen planus is linked to several autoimmune diseases.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.